Table 1 Demographic and clinical characteristics of study participants

Age (year), mean ± SD

55.57\(\pm\)17.12

51.72\(\pm\)15.29

0.09

BMI, mean ± SD

27.50\(\pm\)4.27

27.90\(\pm\)4.73

0.52

Sex, n (%)

Female

45 (42.5)

61 (57.5)

Male

56 (54.9)

46 (45.1)

HTN, n (%)

No

73 (47.1)

82 (52.9)

Yes

28 (52.8)

25 (47.2)

DM, n (%)

No

81 (48.8)

85 (51.2)

Yes

20 (47.6)

22 (52.4)

COPD, n (%)

No

100 (49.5)

102 (50.5)

Yes

1 (16.7)

5 (83.5)

CVD, n (%)

No

92 (48.4)

98 (51.6)

Yes

9 (50)

9 (50)

Cancer, n (%)

No

99 (49.7)

100 (50.3)

Yes

2 (22.2)

7 (77.8)

CRF, n (%)

No

96 (48.0)

104 (52.0)

Yes

5 (62.5)

3 (37.5)

Autoimmune disease, n (%)

No

98 (48.0)

106 (52.0)

Yes

3 (75.0)

1 (25.0)

RA, n (%)

No

92 (47.7)

101 (52.3)

Yes

9 (60.0)

6 (40.0)

Dyslipidemia, n (%)

No

96 (49.2)

99 (50.8)

Yes

5 (38.5)

8 (61.5)

Asthma, n (%)

No

95 (49.2)

98 (50.8)

Yes

6 (40.0)

9 (60.0)

SBP, mean ± SD

132.63\(\pm\)19.83

131.32\(\pm\)17.10

DBP, mean ± SD

81.59\(\pm\)14.41

82.78\(\pm\)9.87

T, mean ± SD

36.83\(\pm\)0.69

36.60\(\pm\)0.48

RR, mean ± SD

20.67\(\pm\)7.16

20.58\(\pm\)7.20

 h, mean ± SD

92.25\(\pm\)18.32

92.70\(\pm\)14.11

O₂ SAT, mean ± SD

89.80\(\pm\)6.28

91.60\(\pm\)4.96

WBC, mean ± SD

5.99\(\pm\)2.93

5.51\(\pm\)2.43

Neutrophil, mean ± SD

78.47\(\pm\)8.66

77.64\(\pm\)9.67

NLR, mean ± SD

4.63\(\pm\)2.74

4.94\(\pm\)5.24

Platelet, mean ± SD

186.55\(\pm\)71.35

198.05\(\pm\)90.60

AST, mean ± SD

41.87\(\pm\)24.68

43.66\(\pm\)40.38

ALT, mean ± SD

39.37\(\pm\)35.10

40.95\(\pm\)36.13

CRP, mean ± SD

73.91\(\pm\)54.30

74.97\(\pm\)49.92